{"name": "Fedora Pharmaceuticals",
 "permalink": "fedora-pharmaceuticals",
 "crunchbase_url": "http://www.crunchbase.com/company/fedora-pharmaceuticals",
 "homepage_url": "http://fedorapharma.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "FedoraPharma",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2012,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@fedorapharma.com",
 "phone_number": "780-989-9845 ",
 "description": "",
 "created_at": "Mon May 27 15:20:27 UTC 2013",
 "updated_at": "Mon May 27 15:31:47 UTC 2013",
 "overview": "\u003Cp\u003EFedora Pharmaceuticvals Inc. is a Canadian-based biotechnology company focussed on developing agents to overcome antibiotics resistance. Fedora was founded based on technology in-licensed from NAEJA Pharmaceuticals Inc. NAEJA\u0026#8217;s scientists discovered a new series of Beta-Lactamase inhibitors that restores beta-lactam antibiotic (suuch as Penicillin, Ceftazidime) activities.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       36],
      "assets/images/resized/0026/7641/267641v1-max-150x150.png"],
     [[250,
       60],
      "assets/images/resized/0026/7641/267641v1-max-250x250.png"],
     [[450,
       108],
      "assets/images/resized/0026/7641/267641v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "President and CEO",
    "person":
     {"first_name": "Christopher",
      "last_name": "G. Micetich",
      "permalink": "christopher-g-micetich",
      "image": null}},
   {"is_past": false,
    "title": "Chief Scientific Officer",
    "person":
     {"first_name": "Thomas",
      "last_name": "Parr",
      "permalink": "thomas-parr",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$200k",
 "funding_rounds":
  [{"round_code": "seed",
    "source_url": "http://www.sec.gov/Archives/edgar/data/1576423/000157642313000001/xslFormDX01/primary_doc.xml",
    "source_description": "SEC",
    "raised_amount": 200100.0,
    "raised_currency_code": "USD",
    "funded_year": 2013,
    "funded_month": 5,
    "funded_day": 14,
    "investments":
     []}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "4290-91A Street",
    "address2": "",
    "zip_code": "T6E 5V2",
    "city": "Edmonton",
    "state_code": null,
    "country_code": "CAN",
    "latitude": 53.4797521,
    "longitude": -113.4686783}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        94],
       "assets/images/resized/0026/7640/267640v1-max-150x150.png"],
      [[250,
        157],
       "assets/images/resized/0026/7640/267640v1-max-250x250.png"],
      [[450,
        283],
       "assets/images/resized/0026/7640/267640v1-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}